Identifying Prognostic Significance of RCL1 and Four-Gene Signature as Novel Potential Biomarkers in HCC Patients

BACKGROUND: Hepatocellular carcinoma (HCC) is a highly malignant disease, and it is characterized by rapid progression and low five-year survival rate. At present, there are no effective methods for monitoring the treatment and prognosis of HCC. METHODS: The transcriptome and gene expression profile...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jun, Zhang, Shan-Qiang, Chen, Jing, Li, Zhi-Bin, Chen, Jia-Xi, Lu, Qi-Qi, Han, Yu-Shuai, Dai, Wenjie, Xie, Chongwei, Li, Ji-Cheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260302/
https://www.ncbi.nlm.nih.gov/pubmed/34257652
http://dx.doi.org/10.1155/2021/5574150

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8260302/
https://www.ncbi.nlm.nih.gov/pubmed/34257652
http://dx.doi.org/10.1155/2021/5574150

Ejemplares similares